Literature DB >> 15922736

Evidence that membrane transduction of oligoarginine does not require vesicle formation.

Jennica L Zaro1, Wei-Chiang Shen.   

Abstract

The involvement of vesicular formation processes in the membrane transduction and nuclear transport of oligoarginine is currently a subject of controversy. In this report, a novel quantitative method which allows for the selective measurement of membrane transduction excluding concurrent endocytosis was used to determine the effects of temperature, endosomal acidification, endosomolysis, and several known inhibitors of endocytic pathways on the internalization of oligoarginine. The results show that, unlike endocytosis, transduction of oligoarginine was not affected by incubation at 16 degrees C as compared to the 37 degrees C control, and was only partially inhibited at 4 degrees C incubation. Additionally, membrane transduction was not inhibited to the same extent as endocytosis following treatment with ammonium chloride, hypertonic medium, amiloride, or filipin. The endosomolytic activity of oligoarginine was investigated by examining the leakage of FITC-dextran into the cytosolic compartment, which was not higher in the presence of oligoarginine. Furthermore, ammonium chloride showed no effect on the nuclear transport of oligoarginine. The data presented in this report indicate that membrane transduction is likely to occur at the plasma membrane without the formation of membrane vesicles, and the nuclear localization involves membrane transduction, rather than endocytosis of oligoarginine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922736     DOI: 10.1016/j.yexcr.2005.02.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

Review 2.  The design of guanidinium-rich transporters and their internalization mechanisms.

Authors:  Paul A Wender; Wesley C Galliher; Elena A Goun; Lisa R Jones; Thomas H Pillow
Journal:  Adv Drug Deliv Rev       Date:  2007-11-09       Impact factor: 15.470

3.  Design of aromatic-containing cell-penetrating peptide mimics with structurally modified π electronics.

Authors:  Brittany M deRonde; Alexander Birke; Gregory N Tew
Journal:  Chemistry       Date:  2014-12-23       Impact factor: 5.236

4.  Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.

Authors:  Laura Cascales; Sónia T Henriques; Markus C Kerr; Yen-Hua Huang; Matthew J Sweet; Norelle L Daly; David J Craik
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

5.  Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.

Authors:  Robert H Mo; Jennica L Zaro; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2011-12-28       Impact factor: 4.939

6.  Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells.

Authors:  Jennica L Zaro; Jacqueline E Vekich; Thuy Tran; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

7.  Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus.

Authors:  Naoki Kajiwara; Namiko Nomura; Masako Ukaji; Naoki Yamamoto; Michinori Kohara; Fumihiko Yasui; Yoshihiro Sakoda; Hiroshi Kida; Futoshi Shibasaki
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

Review 8.  Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways.

Authors:  Zuhong Li; Yanhong Zhang; Danhua Zhu; Shuiqing Li; Xiaopeng Yu; Yalei Zhao; Xiaoxi Ouyang; Zhongyang Xie; Lanjuan Li
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.